Back to Search
MICHAEL MESSING, MD
MD
Diagnostic Radiology Physician
NPI: 1740219351IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
036075709(IL)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1986
Research & Publications (6)
Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche.
PMID 19285048·Brain Res·2009
7-preclinical
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
PMID 19224848·J Clin Oncol·2009
3-trial
Controlled polytypic and twin-plane superlattices in iii-v nanowires.
PMID 19119283·Nat Nanotechnol·2009
8-other
Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
PMID 16509483·J Neurosurg·2006
5-case
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.
PMID 15297200·Gynecol Oncol·2004
3-trial
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
PMID 11925132·Gynecol Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 17501 BISCAYNE BLVD STE 540
AVENTURA, FL 33160 - Phone
- (954) 233-0736
Quick Facts
- NPI
- 1740219351
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 6
Are you this provider?
Claim Your Profile